Why does my son or daughter keep going to treatment and nothing changes?
Because treatment and recovery are two different things, and most families have only ever been sold the first one. A residential program is an acute episode of care, usually 30 to 90 days, and what happens in the weeks after discharge determines the outcome far more than which facility your child slept in.
There is one number that reframes this entire problem for most parents. In a follow-up of patients discharged after detoxification, within nine months the abstinence rate for those with no formal aftercare was only 6 percent, compared with 50 percent for those in outpatient aftercare and 67 percent for those in inpatient aftercare, as summarized in a 2022 review in Frontiers in Psychiatry. Sit with the size of that gap. The difference between 6 percent and 67 percent was not the quality of the treatment episode. It was whether anything structured existed on the other side of the exit door.
This is why the pattern repeats. Each admission solves the acute crisis, which is real and often lifesaving. Detox stabilizes the body. Thirty days of structure interrupts the chaos. Your son or daughter calls you clear headed and hopeful, and for the first time in months you sleep. Then discharge day arrives, the structure ends in a single afternoon, and the person walks back into the same apartment, the same phone, the same relationships, and the same nervous system, now carrying the added weight of everyone's expectations.
Nothing in that handoff was designed to hold. So the cycle runs again, and each time it does, the family concludes that the problem must be the person or the program. Usually it is neither. It is the seam between them.
Is it normal for someone to go through 10, 20, or more treatment centers?
It is more common than the treatment industry advertises, and it does not mean your child is an outlier or a lost cause. People with 10, 20, 30, and in rare cases more than 60 documented treatment episodes exist in every region of this country, and they are frequently people whose families had the resources to keep paying for one more admission.
Preston Durnford has spent over a decade owning and operating treatment centers and has personally worked with people who had been through dozens of programs before anyone stopped to ask why. That is a lived clinical observation, not a statistic, and it matters because most parents in this situation believe they are the only ones.
The research points in the same direction. Repeated episodes do not reliably compound into recovery on their own. In one study cited in the Frontiers in Psychiatry review, the relapse rate for heroin patients who had been through a single detoxification was roughly 60 percent, while for those with multiple prior detoxifications it ran as high as 88 percent.
That number is not a verdict on those people. It is a description of what happens when the same intervention is delivered the same way into the same unchanged environment, over and over. Each repetition also carries a cost the brochures do not mention. It teaches the person that they fail at this, it drains the family financially and emotionally, and it slowly converts hope into resignation on both sides.
If your family is somewhere in the double digits, the useful question is no longer whether to try treatment again. It is what has never actually been tried.
Does relapse mean the treatment failed, or that my child is not trying?
Neither, in most cases. The National Institute on Drug Abuse reports that 40 to 60 percent of people treated for a substance use disorder return to use, a rate comparable to relapse in chronic conditions such as high blood pressure and asthma, which run roughly 50 to 70 percent.
NIDA is explicit that a return to use does not mean treatment failed. It is a signal that the treatment plan needs to be resumed, adjusted, or replaced, the same way a spike in blood pressure means the medication needs revisiting rather than proving the patient is weak.
This framing came from a landmark 2000 review in JAMA by McLellan and colleagues, Drug Dependence, a Chronic Medical Illness, which compared substance dependence directly against type 2 diabetes, hypertension, and asthma across heritability, causes, and treatment response, and found them broadly comparable. Their argument was that we evaluate addiction treatment by a standard we apply to no other chronic illness. We expect a single time limited episode to produce permanent cure, and when it does not, we blame the patient.
No cardiologist discharges a patient after 30 days and calls it done. No endocrinologist treats a blood sugar spike as evidence of bad character. Yet that is precisely the logic families are handed at the end of every admission.
So when your son or daughter uses again three weeks after coming home, you are not looking at proof that they do not want it badly enough. You are looking at the predictable behavior of a chronic condition that received acute care and then nothing. The wanting was almost certainly there. The scaffolding was not.
What actually happens in the days and weeks after discharge?
The highest risk period begins the moment the structure ends, and it stays elevated through roughly the first six months. This is the window where nearly all of the damage happens, and it is also the window that almost nobody is being paid to cover.
The timing is well documented. In a long term follow up of people treated for methamphetamine use, published in Drug and Alcohol Dependence, 36 percent had no abstinent months at all directly following discharge, another 14 percent relapsed in months two through six, and 61 percent had relapsed within the first year. The authors noted that the sharpest drop in the probability of continued abstinence occurred early in the post treatment period. In a separate study of inpatient opiate treatment published in the Irish Medical Journal, 91 percent of patients reported a relapse, and in 59 percent of those cases the first relapse happened within one week of leaving.
Consider what that week actually looks like from the inside. The person goes from a fully scheduled day with 24 hour supervision, peers, meals, and multiple clinicians to an empty Tuesday afternoon alone in an apartment. Sleep is still poor. Mood is unstable. Old contacts are still in the phone. Whatever was underneath the substance use, the trauma, the untreated psychiatric condition, the physical dysregulation, is now fully unmedicated by the drug and fully unsupported by the program.
Meanwhile the family, exhausted and hopeful, backs off to give them space. The result is that support hits its lowest point in the exact window where risk hits its highest point. That inversion is the whole problem, and it is designed into the way care is currently paid for and delivered.
Why does aftercare matter more than which treatment center we choose?
Because the data on aftercare separates outcomes far more sharply than the data on any particular facility. The 6 percent, 50 percent, and 67 percent figures cited in the Frontiers in Psychiatry review describe patients who all received treatment. What differed was only what came next, and the outcomes differed by a factor of more than ten.
The Irish Medical Journal study found the same thing from a different direction. Among the predictors of earlier relapse, alongside younger age and history of injecting, was failure to enter aftercare. The authors' recommendation was not to build better inpatient units. It was that services should actively support patients into planned aftercare in order to improve outcomes.
Most families spend their research energy in the wrong place. They compare amenities, accreditation, clinical philosophies, and locations. Those things are not meaningless, but they are second order. The first order question is what specifically will exist on day 31, day 60, and day 120, who owns it, and whether it was arranged before discharge or left as a stack of phone numbers.
The honest answer at most programs is that aftercare is a printed list handed over at checkout, a referral to an outpatient group with a three week waitlist, and a follow up call at 30 days for outcome tracking. That is not a handoff. That is a hope.
If you are evaluating what to do next after multiple failed episodes, ask every provider one question. Who is responsible for the first six months after discharge, by name, and what happens when my son or daughter stops answering the phone?
Did we do something wrong by paying for all of this?
No. You acted on the best information you were given, repeatedly, at enormous cost, and every one of those admissions kept your child alive through a crisis that could have ended differently.
Families in this position carry a specific kind of guilt that deserves to be named directly. Parents replay the decisions. The program they chose in year two. The intervention they did not do. The money they spent, or the money they stopped spending. The moment they set a boundary, or the moment they did not. Many parents in this situation have spent well into six figures and quietly wonder whether they enabled the whole thing.
Here is what the evidence actually supports. The JAMA review found that heritability, environment, and personal choice contribute to substance dependence in proportions broadly comparable to diabetes, hypertension, and asthma. Nobody tells the parent of an asthmatic child that the attacks are their fault.
What is worth examining is not your character but the model you were working inside. You were sold an acute product for a chronic condition, and then handed the emotional bill when it behaved exactly as the research predicts. That is a failure of system design, not of parenting.
There is also a practical reason to set the guilt down. Families operating from shame make worse decisions. They over function, they under function, they swing between rescuing and cutting off, and they say yes to the next program out of desperation rather than judgment. Clear eyes are more useful to your son or daughter right now than penance is.
What does a different approach look like after many failed treatment episodes?
It looks like putting the resources into the window where the risk actually lives, which is the months after discharge rather than the weeks inside a facility. It also looks like treating what is underneath the substance use, medically, psychiatrically, and physically, rather than treating only the substance use itself.
Epic Journey Recovery was built specifically for that gap. It is concierge recovery coaching based in Newport Beach, California. It is not a treatment facility. There are no beds, it is not licensed treatment, it is cash pay, and it does not bill insurance. Work is mainly virtual and available nationwide, with in person support across Orange County.
The structure is a 90 day core engagement with the full team. Most people stay up to about six months, and from there many taper to roughly one session a week and continue with whichever team member they connected with most. The team is about 12 people, including Preston plus coaches, holistic practitioners, functional medicine, a neurologist, a psychiatrist, and licensed therapists. That mix exists because a person with 20 treatment episodes usually has something unaddressed underneath, and a single modality has already been tried repeatedly.
Preston Durnford founded the practice in 2014. He has been sober over a decade, has spent 11 plus years owning and operating treatment centers, has led 500 plus interventions, and wrote The Epic Journal, which has sold more than 30,000 copies.
Nothing here prevents relapse, and any provider who tells you otherwise is selling something. What this approach does is put continuous, coordinated, accountable support into the exact window where the research says people are most likely to lose ground alone.
If your family is somewhere in the double digits and out of ideas, you can book a free consult with Preston and talk through what has already been tried.
Questions people ask
How many times do people usually relapse before recovery holds?
There is no reliable number, and any provider who quotes one is guessing. NIDA reports that 40 to 60 percent of people treated for a substance use disorder return to use, similar to chronic conditions like asthma and hypertension. What the research does show consistently is that outcomes improve substantially when structured support continues after discharge rather than ending at it.
Should we pay for another treatment center?
That depends less on the facility and more on what is planned for after it. If the previous episodes ended with a printed referral list and no owned handoff, another admission is likely to repeat the same pattern. Before committing more money, ask who is responsible for the first six months post discharge, by name, and what happens if your son or daughter disengages.
Is Epic Journey Recovery a treatment center or rehab?
No. Epic Journey Recovery is concierge recovery coaching based in Newport Beach, California. There are no beds, it is not licensed treatment, and it does not bill insurance. It is cash pay, mainly virtual and available nationwide, with in person support across Orange County. It is designed to work in the period after treatment, not to replace medical detox or acute care.
How long does an engagement with Epic Journey last?
The core engagement is 90 days with the full team of about 12 practitioners. Most people stay up to about six months. After that, many taper down to roughly one session a week and continue with whichever team member they connected with most, whether that is a coach, a therapist, or one of the medical practitioners. The shape adapts to the person rather than the reverse.
What if our son or daughter refuses help right now?
That is common and it is not the end of the conversation. Preston has led over 500 interventions and works with families directly, not only with the person using. A consult can be a conversation about what the family does next, how to set workable boundaries, and how to prepare a real post discharge structure before the next window of willingness opens.
Sources
- NIDA, Drugs, Brains, and Behavior: Treatment and Recovery
- McLellan et al., Drug Dependence, a Chronic Medical Illness, JAMA 2000
- Liu, Lu & Xie, Tracking Study on Relapse and Aftercare Effect, Frontiers in Psychiatry 2022
- Smyth et al., Lapse and Relapse Following Inpatient Treatment of Opiate Dependence, Irish Medical Journal 2010
- Brecht & Herbeck, Time to Relapse Following Treatment for Methamphetamine Use, Drug and Alcohol Dependence 2014
